Wen Q - Search Results

1

The Risk of Immune-Related Thyroid Dysfunction Induced by PD-1/PD-L1 Inhibitors in Cancer Patients: An Updated Systematic Review and Meta-Analysis.

Tian Y, Li R, Liu Y, Li M, Song Y, Zheng Y, Gao A, Wen Q, Su G, Sun Y. Tian Y, et al. Among authors: wen q. Front Oncol. 2021 Jul 12;11:667650. doi: 10.3389/fonc.2021.667650. eCollection 2021. Front Oncol. 2021. PMID: 34322382 Free PMC article.

2

The prognostic landscape of tumor-infiltrating immune cells in cervical cancer.

Wang J, Li Z, Gao A, Wen Q, Sun Y. Wang J, et al. Among authors: wen q. Biomed Pharmacother. 2019 Dec;120:109444. doi: 10.1016/j.biopha.2019.109444. Epub 2019 Sep 25. Biomed Pharmacother. 2019. PMID: 31562978 Free article.

3

Tian Y, Gao A, Wen Q, Wang S, Zhang S, Yang X, Su G, Sun Y. Tian Y, et al. Among authors: wen q. Front Immunol. 2020 Dec 18;11:595655. doi: 10.3389/fimmu.2020.595655. eCollection 2020. Front Immunol. 2020. PMID: 33391266 Free PMC article.

4

Immune subgroup analysis for non-small cell lung cancer may be a good choice for evaluating therapeutic efficacy and prognosis.

Tian Y, Wang J, Wen Q, Su G, Sun Y. Tian Y, et al. Among authors: wen q. Aging (Albany NY). 2021 May 11;13(9):12691-12709. doi: 10.18632/aging.202941. Epub 2021 May 11. Aging (Albany NY). 2021. PMID: 33973529 Free PMC article.

5

Assessment of the Clinical Trials Safety Profile of PD-1/PD-L1 Inhibitors Among Patients With Cancer: An Updated Systematic Review and Meta-Analysis.

Tian Y, Huang A, Yang Y, Dang Q, Wen Q, Wang L, Sun Y. Tian Y, et al. Among authors: wen q. Front Oncol. 2021 May 24;11:662392. doi: 10.3389/fonc.2021.662392. eCollection 2021. Front Oncol. 2021. PMID: 34109117 Free PMC article.

6

The Significance of Tumor Microenvironment Score for Breast Cancer Patients.

Tian Y, Wang J, Wen Q, Gao A, Huang A, Li R, Zhang Y, Su G, Sun Y. Tian Y, et al. Among authors: wen q. Biomed Res Int. 2022 Apr 28;2022:5673810. doi: 10.1155/2022/5673810. eCollection 2022. Biomed Res Int. 2022. PMID: 35528180 Free PMC article.

7

Effect of Food Intake on Pharmacokinetics of Oral Almonertinib: A Randomized Crossover Trial in Healthy Chinese Participants.

Ji W, Jiang Y, Wei Y, He K, Mu H, Wen Q, Zhang X. Ji W, et al. Among authors: wen q. Clin Pharmacol Drug Dev. 2022 Sep;11(9):1046-1053. doi: 10.1002/cpdd.1095. Epub 2022 Apr 18. Clin Pharmacol Drug Dev. 2022. PMID: 35437951 Clinical Trial.

8

Pharmacokinetic comparison of nalbuphine with single injection and patient-controlled analgesia mimic method in healthy Chinese volunteers.

He K, Ji W, Zhao H, Wei Y, Yang S, Wen Q. He K, et al. Among authors: wen q. J Clin Pharm Ther. 2021 Aug;46(4):1166-1172. doi: 10.1111/jcpt.13421. Epub 2021 May 3. J Clin Pharm Ther. 2021. PMID: 33942343

9

Rapid quantitative analysis of etoricoxib in human plasma by UPLC-MS/MS and application to a pharmacokinetic study in Chinese healthy volunteers.

Zhang X, Guo N, Ji W, Wen Q. Zhang X, et al. Among authors: wen q. Biomed Chromatogr. 2019 Feb;33(2):e4414. doi: 10.1002/bmc.4414. Epub 2018 Nov 22. Biomed Chromatogr. 2019. PMID: 30360014 Clinical Trial.

10

Prediction of janagliflozin pharmacokinetics in type 2 diabetes mellitus patients with liver cirrhosis or renal impairment using a physiologically based pharmacokinetic model.

Zhao H, Wei Y, He K, Zhao X, Mu H, Wen Q. Zhao H, et al. Among authors: wen q. Eur J Pharm Sci. 2022 Dec 1;179:106298. doi: 10.1016/j.ejps.2022.106298. Epub 2022 Sep 23. Eur J Pharm Sci. 2022. PMID: 36162752 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,308 results

Search Page

Filters